Le Lézard
Classified in: Health
Subjects: CCA, FVT

West to Host Third-Quarter 2018 Conference Call


EXTON, Pa., Oct. 11, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2018 financial results before the market opens on Thursday, October 25, 2018, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call, please dial 877-930-8295 (U.S.) or 253-336-8738 (International). The conference ID is 8341499.

(PRNewsfoto/West Pharmaceutical Services, I)

A live broadcast of the conference call will be available at the Company's website, www.westpharma.com, in the "Investors" section. Management will refer to a slide presentation during the call, which will be made available on the day of the call. To view the presentation, select "Presentations" in the "Investors" section of the Company's website.

An online archive of the broadcast will be available at the site three hours after the live call and will be available through Thursday, November 1, 2018, by dialing 855-859-2056 (U.S.) or 404-537-3406 (International). The conference ID is 8341499.

About West
West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West's 2017 net sales of $1.6 billion reflect the daily use of approximately 112 million of its components and devices, which are designed to improve the delivery of healthcare to patients around the world.

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.

Investor Contact:

Media Contact:

Quintin Lai

Emily Denney

Vice President, Investor Relations

Vice President, Global Communications

+1-610-594-3318

+1-610-594-3035

[email protected] 

[email protected]

 

SOURCE West Pharmaceutical Services, Inc.


These press releases may also interest you

at 13:00
Starting next week, the Network of National Library of Medicine and Columbus Metropolitan Library in Columbus, OH will host the All of Us Journey. This traveling educational exhibit brings the National Institutes of Health's All of Us Research...

at 13:00
$56.5M Equity Financing Led by Questa Capital, Laerdal Million Lives Fund, and Catalyst Health Ventures, with New Participation from RC Capital and Eckuity CapitalAvive has rapidly built an expansive and diverse customer base, delivering its FDA...

at 13:00
Lynx Dx, a leader in innovative diagnostic solutions, hailed new peer-reviewed research published today in the Journal of the American Medical Association (JAMA) Oncology that validates the efficacy of MyProstateScore 2.0 (MPS2), the company's...

at 12:50
Data infrastructure and analytics company Kalderos, Inc., today announced that on Tuesday, April 16, it asked the Eighth Circuit for leave to file an amicus brief in support of Pharmaceutical Research and Manufacturers of America's (PhRMA's) petition...

at 12:20
Titan CEO and headline sponsor Wipfli LLP are pleased to announce Judith Nowlin, CEO of Nest Collaborative as a 2024 Colorado Titan 100. The Titan 100 program recognizes Colorado's Top 100 CEOs & C-level executives. They are the area's most...

at 12:18
Memorial Healthcare System and Solis Mammography, are pleased to announce the opening of the collaboration's first community-based breast screening centers in Weston, Plantation and Hialeah, Florida. The centers represent the commitment that both...



News published on and distributed by: